NO20080439L - Amylaser til farmasoytisk anvendelse - Google Patents

Amylaser til farmasoytisk anvendelse

Info

Publication number
NO20080439L
NO20080439L NO20080439A NO20080439A NO20080439L NO 20080439 L NO20080439 L NO 20080439L NO 20080439 A NO20080439 A NO 20080439A NO 20080439 A NO20080439 A NO 20080439A NO 20080439 L NO20080439 L NO 20080439L
Authority
NO
Norway
Prior art keywords
amylases
bacillus
pharmaceutical use
diabetes
type
Prior art date
Application number
NO20080439A
Other languages
English (en)
Norwegian (no)
Inventor
Peter-Colin Gregory
Allan Svendsen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of NO20080439L publication Critical patent/NO20080439L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20080439A 2005-06-24 2008-01-23 Amylaser til farmasoytisk anvendelse NO20080439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500931 2005-06-24
PCT/DK2006/000354 WO2006136161A2 (en) 2005-06-24 2006-06-16 Amylases for pharmaceutical use

Publications (1)

Publication Number Publication Date
NO20080439L true NO20080439L (no) 2008-03-04

Family

ID=34956782

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080439A NO20080439L (no) 2005-06-24 2008-01-23 Amylaser til farmasoytisk anvendelse

Country Status (15)

Country Link
US (1) US8017351B2 (pt)
EP (1) EP1896057A2 (pt)
JP (1) JP2008546396A (pt)
KR (1) KR20080031868A (pt)
CN (1) CN101242853A (pt)
AU (1) AU2006261444A1 (pt)
BR (1) BRPI0611932A2 (pt)
CA (1) CA2612811A1 (pt)
IL (1) IL187635A0 (pt)
MX (1) MX2007015471A (pt)
NO (1) NO20080439L (pt)
NZ (1) NZ563737A (pt)
RU (1) RU2008102650A (pt)
WO (1) WO2006136161A2 (pt)
ZA (1) ZA200710644B (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008012638A (es) * 2006-04-04 2008-10-13 Novozymes As Proceso de mezclado.
CA3081308C (en) 2006-12-21 2024-02-20 Novozymes A/S Lipase variants for pharmaceutical use
KR20100092450A (ko) 2007-12-04 2010-08-20 노보자임스 에이/에스 약학적 사용을 위한 프로테아제 변이체
GB2468629B (en) * 2008-06-08 2011-10-26 Tarig Sayed Mustafa Arbab Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
WO2010102041A2 (en) * 2009-03-04 2010-09-10 Meyer Nutriceuticals, Llc Composition and method for control of diabetes
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
WO2011080354A1 (en) 2010-01-04 2011-07-07 Novozymes A/S Alpha-amylases
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2013155476A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
EP3004341B1 (en) 2013-05-29 2017-08-30 Danisco US Inc. Novel metalloproteases
WO2014194034A2 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
EP3004314B1 (en) 2013-05-29 2018-06-20 Danisco US Inc. Novel metalloproteases
EP3004342B1 (en) 2013-05-29 2023-01-11 Danisco US Inc. Novel metalloproteases
EP3080262B1 (en) 2013-12-13 2019-02-06 Danisco US Inc. Serine proteases of bacillus species
EP3080263B1 (en) 2013-12-13 2019-07-03 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
JP6598778B2 (ja) 2013-12-16 2019-10-30 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー ポリα−１，３−グルカンエーテル化合物を含む洗濯洗剤又は衣類柔軟剤
BR112016014014B1 (pt) 2013-12-18 2021-08-10 Nutrition & Biosciences USA 4, Inc. Composição, método para a produção de um composto e método para o tratamento de um material
WO2015123323A1 (en) 2014-02-14 2015-08-20 E. I. Du Pont De Nemours And Company Poly-alpha-1,3-1,6-glucans for viscosity modification
CN103789285B (zh) * 2014-02-19 2016-01-20 江南大学 一种热稳定性提高的淀粉酶突变体及其构建方法和应用
MX2016011467A (es) 2014-03-11 2016-11-16 Du Pont Poli alfa-1,3-glucano oxidado como mejorador de detergente.
CN106170546A (zh) 2014-03-21 2016-11-30 丹尼斯科美国公司 芽孢杆菌属的丝氨酸蛋白酶
CN106661564A (zh) * 2014-04-25 2017-05-10 巴斯夫欧洲公司 淀粉酶变体
WO2015195777A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2016036834A1 (en) * 2014-09-02 2016-03-10 Danisco Us Inc. Dp5-enriched syrups
CN104212780A (zh) * 2014-09-02 2014-12-17 华东理工大学 一种α-淀粉酶及其编码基因与应用
EP3207129B1 (en) 2014-10-17 2019-11-20 Danisco US Inc. Serine proteases of bacillus species
CN107148472A (zh) 2014-10-27 2017-09-08 丹尼斯科美国公司 芽孢杆菌属物种的丝氨酸蛋白酶
EP3957729A1 (en) 2014-10-27 2022-02-23 Danisco US Inc. Serine proteases
EP3212783A1 (en) 2014-10-27 2017-09-06 Danisco US Inc. Serine proteases
DK3212662T3 (da) 2014-10-27 2020-07-20 Danisco Us Inc Serinproteaser
EP3212781B1 (en) 2014-10-27 2019-09-18 Danisco US Inc. Serine proteases
CA2969241A1 (en) 2014-12-23 2016-06-30 E.I. Du Pont De Nemours And Company Enzymatically produced cellulose
RU2733987C2 (ru) 2015-05-13 2020-10-09 ДАНИСКО ЮЭс ИНК. Варианты протеазы клады aprl и их применения
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
EP3307427B1 (en) 2015-06-09 2023-08-16 Danisco US Inc. Osmotic burst encapsulates
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
EP4234693A3 (en) 2015-06-17 2023-11-01 Danisco US Inc Bacillus gibsonii-clade serine proteases
WO2017052455A1 (en) 2015-09-23 2017-03-30 Anara Ab Amylase fragments for blood glucose control
CN109072208A (zh) 2015-11-05 2018-12-21 丹尼斯科美国公司 类芽孢杆菌属物种甘露聚糖酶
CN108603183B (zh) 2015-11-05 2023-11-03 丹尼斯科美国公司 类芽孢杆菌属物种和芽孢杆菌属物种甘露聚糖酶
US10844324B2 (en) 2015-11-13 2020-11-24 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
US10822574B2 (en) 2015-11-13 2020-11-03 Dupont Industrial Biosciences Usa, Llc Glucan fiber compositions for use in laundry care and fabric care
WO2017083226A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
US11920170B2 (en) 2015-12-09 2024-03-05 Danisco Us Inc. Alpha-amylase combinatorial variants
BR112018012020A2 (pt) 2015-12-18 2018-12-04 Danisco Us Inc polipeptídeos com atividade de endoglucanase e usos dos mesmos
EP3452497B1 (en) * 2016-05-03 2021-02-17 Novozymes A/S Alpha-amylase variants and polynucleotides encoding the same
CA3022875A1 (en) 2016-05-03 2017-11-09 Danisco Us Inc Protease variants and uses thereof
BR112018072586A2 (pt) 2016-05-05 2019-02-19 Danisco Us Inc variantes de protease e usos das mesmas
MX2018014768A (es) 2016-05-31 2019-03-06 Danisco Us Inc Variantes de proteasa y sus usos.
EP3251687A1 (en) 2016-06-01 2017-12-06 Centrum Innowacji Edoradca Sp. z o.o. Spolka Komandytowa Bioactive peptides for blood glucose control
CA3027745A1 (en) 2016-06-17 2017-12-21 Danisco Us Inc. Protease variants and uses thereof
GB201614415D0 (en) * 2016-08-24 2016-10-05 Pepsis Ltd Enzymes for the treatment of human enterometabolic dysfunction
WO2018085524A2 (en) 2016-11-07 2018-05-11 Danisco Us Inc Laundry detergent composition
WO2018118950A1 (en) 2016-12-21 2018-06-28 Danisco Us Inc. Bacillus gibsonii-clade serine proteases
EP3559227A1 (en) 2016-12-21 2019-10-30 Danisco US Inc. Protease variants and uses thereof
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
US20200040283A1 (en) 2017-03-31 2020-02-06 Danisco Us Inc Delayed release enzyme formulations for bleach-containing detergents
JP2020527339A (ja) 2017-06-30 2020-09-10 ダニスコ・ユーエス・インク 低凝集の酵素含有粒子
WO2019108599A1 (en) 2017-11-29 2019-06-06 Danisco Us Inc Subtilisin variants having improved stability
EP3728543A1 (en) 2017-12-21 2020-10-28 Danisco US Inc. Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant
EP3749107A1 (en) 2018-02-08 2020-12-16 Danisco US Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
WO2019204486A1 (en) * 2018-04-18 2019-10-24 Baylor College Of Medicine Development of amyloglucosidase as a medicinal food or dietary supplement
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
US20210363470A1 (en) 2018-06-19 2021-11-25 Danisco Us Inc Subtilisin variants
EP3844255A1 (en) 2018-08-30 2021-07-07 Danisco US Inc. Enzyme-containing granules
JP2022503923A (ja) 2018-09-27 2022-01-12 ダニスコ・ユーエス・インク 医療用器具を洗浄するための組成物
EP3887515A1 (en) 2018-11-28 2021-10-06 Danisco US Inc. Subtilisin variants having improved stability
EP3976776A1 (en) 2019-05-24 2022-04-06 Danisco US Inc. Subtilisin variants and methods of use
CN114174486A (zh) 2019-06-06 2022-03-11 丹尼斯科美国公司 用于清洁的方法和组合物
WO2022047149A1 (en) 2020-08-27 2022-03-03 Danisco Us Inc Enzymes and enzyme compositions for cleaning
WO2022165107A1 (en) 2021-01-29 2022-08-04 Danisco Us Inc Compositions for cleaning and methods related thereto
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
WO2023034486A2 (en) 2021-09-03 2023-03-09 Danisco Us Inc. Laundry compositions for cleaning
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2023250301A1 (en) 2022-06-21 2023-12-28 Danisco Us Inc. Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173590D0 (da) 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
US5281526A (en) * 1992-10-20 1994-01-25 Solvay Enzymes, Inc. Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof
ES2236738T3 (es) 1995-05-31 2005-07-16 Medzyme N.V. Composicion para mejorar la digestibilidad y la utilizacion de nutrientes.
AU2692897A (en) * 1996-04-30 1997-11-19 Novo Nordisk A/S Alpha-amylase mutants
WO1999019467A1 (en) 1997-10-13 1999-04-22 Novo Nordisk A/S α-AMYLASE MUTANTS
DK1162995T3 (da) * 1999-03-17 2003-06-23 Solvay Pharm Gmbh Enzymer til behandling af diabetes mellitus type I
US6410295B1 (en) * 1999-03-30 2002-06-25 Novozymes A/S Alpha-amylase variants
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
RU2201763C1 (ru) 2001-12-29 2003-04-10 Закрытое акционерное общество "Брынцалов-А" Полиферментное средство ферестал
DE10260903A1 (de) * 2002-12-20 2004-07-08 Henkel Kgaa Neue Perhydrolasen
CN1745169A (zh) * 2003-02-26 2006-03-08 金克克国际有限公司 产生改变的免疫原应答的淀粉酶及其制备和使用方法
JP2008546394A (ja) * 2005-06-24 2008-12-25 ノボザイムス アクティーゼルスカブ 医薬使用のためのリパーゼ
US20080317726A1 (en) * 2005-06-24 2008-12-25 Novozymes A/S Proteases for Pharmaceutical Use

Also Published As

Publication number Publication date
AU2006261444A1 (en) 2006-12-28
CN101242853A (zh) 2008-08-13
CA2612811A1 (en) 2006-12-28
MX2007015471A (es) 2008-04-04
BRPI0611932A2 (pt) 2011-01-04
WO2006136161A2 (en) 2006-12-28
US8017351B2 (en) 2011-09-13
EP1896057A2 (en) 2008-03-12
WO2006136161A3 (en) 2007-07-05
US20090035293A1 (en) 2009-02-05
KR20080031868A (ko) 2008-04-11
ZA200710644B (en) 2008-11-26
IL187635A0 (en) 2008-03-20
JP2008546396A (ja) 2008-12-25
NZ563737A (en) 2010-08-27
RU2008102650A (ru) 2009-07-27

Similar Documents

Publication Publication Date Title
NO20080439L (no) Amylaser til farmasoytisk anvendelse
DK1755656T3 (da) Enzymer til farmaceutisk anvendelse
NO20080438L (no) Proteaser til farmasoytisk anvendelse
NO20080437L (no) Lipaser til farmasoytisk anvendelse
NO20092729L (no) Lipasevarianter for farmasoytisk anvendelse
MX2010005690A (es) Variantes de proteasa para uso farmaceutico.
WO2005111203A3 (en) MUTANT α ΑMYLASES
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
BRPI0915531A2 (pt) Composição de enzima de sacarificação e método de sacarificação da mesma
GB2511713A (en) Methods of treating behavioral symptoms of neurological and mental disorders
NZ595193A (en) Modified Proteases That Inhibit Complement Activation
NO20064306L (no) Laktamer som konformasjonelt begrensede peptidomimetiske inhibitorer
WO2008112459A3 (en) Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
MX354776B (es) Enzimas de reemplazo lisosomal para usarse en el tratamiento de enfermedades de almacenamiento lisosomal.
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX2007005166A (es) Plantas de algodon tolerantes a la agresion.
DK1162995T3 (da) Enzymer til behandling af diabetes mellitus type I
RU2011102781A (ru) ПРИМЕНЕНИЕ Hsp70 В КАЧЕСТВЕ РЕГУЛЯТОРА ФЕРМЕНТАТИВНОЙ АКТИВНОСТИ
WO2009091994A3 (en) Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
WO2009100348A3 (en) Peptides and peptide mimetics to treat pathologies associated with eye disease
TNSN07396A1 (en) Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
WO2007125545A3 (en) Transmucosal composition
JP2008521906A5 (pt)
TW200726842A (en) Mutant glucose dehydrogenase
WO2003086452A3 (en) Methods of enhancing lysosomal storage disease therapy

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application